Cas no 80321-63-7 (Gypenoside IX)

Gypenoside IX is a bioactive saponin compound primarily derived from Gynostemma pentaphyllum (Jiaogulan). It exhibits notable pharmacological properties, including antioxidant, anti-inflammatory, and potential neuroprotective effects. Structurally, it belongs to the dammarane-type triterpenoid saponins, characterized by its specific sugar moieties and aglycone core. Research suggests Gypenoside IX may modulate cellular signaling pathways, such as AMPK and NF-κB, contributing to its therapeutic potential in metabolic and inflammatory disorders. Its high purity and standardized isolation make it suitable for pharmacological studies and nutraceutical applications. Analytical methods like HPLC and LC-MS ensure consistent quality, supporting its use in research on natural product-derived therapeutics.
Gypenoside IX structure
Gypenoside IX structure
Product Name:Gypenoside IX
CAS No:80321-63-7
MF:C47H80O17
MW:917.127917289734
CID:721475
PubChem ID:46887681
Update Time:2025-05-28

Gypenoside IX Chemical and Physical Properties

Names and Identifiers

    • b-D-Glucopyranoside, (3b,12b)-3-(b-D-glucopyranosyloxy)-12-hydroxydammar-24-en-20-yl 6-O-b-D-xylopyranosyl-
    • 3-O-β-D-Glucopyranosyl-20-O-<α-L-arabinopyranosyl(1->6)-β-D-glucopyranosyl>-20(S)-protopanaxadiol
    • Notoginsenoside Fd
    • Stevenleaf
    • Ginsenoside C-Mx1
    • Gynosaponin I
    • Gynostemma Extract
    • Gypenoside
    • GYPENOSIDE IX
    • SS-D-GLUCOPYRANOSIDE, (3SS,12SS)-3-(SS-D-GLUCOPYRANOSYLOXY)-12-HYDROXYDAMMAR-24-EN-20-YL 6-O-SS-D-XYLOPYRANOSYL-
    • (3beta,12beta)-3-(beta-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-20-yl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
    • 2-(Hydroxymethyl)-6-[[(5S,8R,9R,10R,13R,14R)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-
    • CG0047
    • SW219585-1
    • (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[[(3S,5R,8R,9S,10R,12R,13R,14R,17R)-12-hydroxy-4,4,8,10,14-pent
    • (3β,12β)-3-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-20-yl 6-O-β-D-xylopyranosyl-β-D-glucopyranoside (ACI)
    • Dammarane, β-D-glucopyranoside deriv. (ZCI)
    • 3-O-Glucosylginsenoside C-Mx
    • MS-31714
    • Ginsenoside C-Mx1; Gynosaponin I; Gypenoside IX
    • (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol
    • AC-34770
    • AKOS022168210
    • s2306
    • BDBM50317535
    • CCG-270573
    • CHEMBL1095009
    • Gynostemma pentaphyllum
    • CS-5342
    • NCGC00386168-01
    • 80321-63-7
    • DTXSID001317599
    • HY-N0167
    • B0005-479871
    • FT-0777164
    • 2-(hydroxymethyl)-6-[[12-hydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol
    • (2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2S)-6-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}hept-5-en-2-yl]-dodecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
    • BRD-K58775955-001-02-4
    • DA-67789
    • Gypenoside IX
    • MDL: MFCD10566702
    • Inchi: 1S/C47H80O17/c1-22(2)10-9-14-47(8,64-42-39(58)36(55)34(53)27(62-42)21-60-40-37(56)32(51)25(50)20-59-40)23-11-16-46(7)31(23)24(49)18-29-44(5)15-13-30(43(3,4)28(44)12-17-45(29,46)6)63-41-38(57)35(54)33(52)26(19-48)61-41/h10,23-42,48-58H,9,11-21H2,1-8H3/t23-,24+,25+,26+,27+,28-,29+,30-,31-,32-,33+,34+,35-,36-,37+,38+,39+,40-,41-,42-,44-,45+,46+,47-/m0/s1
    • InChI Key: ZTQSADJAYQOCDD-HUGMCNGHSA-N
    • SMILES: C[C@@]12CC[C@H]3C([C@H](CC[C@]3(C)[C@H]1C[C@@H](O)[C@@H]1[C@H](CC[C@@]21C)[C@](C)(CC/C=C(\C)/C)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)O1)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)(C)C

Computed Properties

  • Exact Mass: 916.54000
  • Monoisotopic Mass: 916.53955108 g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 11
  • Hydrogen Bond Acceptor Count: 17
  • Heavy Atom Count: 64
  • Rotatable Bond Count: 12
  • Complexity: 1630
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 18
  • Undefined Atom Stereocenter Count : 6
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Surface Charge: 0
  • Tautomer Count: nothing
  • XLogP3: 1.9
  • Topological Polar Surface Area: 278
  • Molecular Weight: 917.1

Experimental Properties

  • Color/Form: White powder
  • Density: 1.36
  • Melting Point: No data available
  • Boiling Point: 982.5±65.0 °C at 760 mmHg
  • Flash Point: 548.0±34.3 °C
  • Refractive Index: 1.597
  • Solubility: 生物體外In Vitro:DMSO溶解度25 mg/mL(27.26 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble)
  • PSA: 277.91000
  • LogP: 0.61230

Gypenoside IX Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM182265-100mg
Gynostemma Extract
80321-63-7 98%
100mg
$524 2021-06-15
DC Chemicals
DCAPI1350-1 g
Gynostemma Extract
80321-63-7 >99%
1g
$1500.0 2022-02-28
DC Chemicals
DCAPI1350-100 mg
Gynostemma Extract
80321-63-7 >99%
100mg
$375.0 2022-02-28
DC Chemicals
DCAPI1350-250 mg
Gynostemma Extract
80321-63-7 >99%
250mg
$750.0 2022-02-28
S e l l e c k ZHONG GUO
S2306-10mM (1mL in DMSO)
Gynostemma Extract
80321-63-7
10mM (1mL in DMSO)
¥3446.31 2023-09-16
S e l l e c k ZHONG GUO
S2306-10mg
Gynostemma Extract
80321-63-7
10mg
¥2636.51 2023-09-16
S e l l e c k ZHONG GUO
S2306-50mg
Gynostemma Extract
80321-63-7
50mg
¥7943.27 2022-04-26
S e l l e c k ZHONG GUO
S2306-200mg
Gynostemma Extract
80321-63-7
200mg
¥20229.3 2023-09-16
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S84880-20mg
Gynostemma Extract
80321-63-7
20mg
¥48.0 2021-09-07
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S84881-20mg
Gynostemma Extract
80321-63-7
20mg
¥988.0 2021-09-07

Gypenoside IX Production Method

Production Method 1

Reaction Conditions
1.1 Catalysts: Ginsenoside glycosidase Solvents: Water ;  120 min, pH 5.0, 45 °C
1.2 Reagents: 1-Butanol Solvents: Water
Reference
Biotransformation pathway and kinetics of the hydrolysis of the 3-O- and 20-O-multi-glucosides of PPD-type ginsenosides by ginsenosidase type I
Liu, Chunying; et al, Process Biochemistry (Oxford, 2014, 49(5), 813-820

Gypenoside IX Raw materials

Gypenoside IX Preparation Products

Recommended suppliers
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd